Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere
- PMID: 20832198
- DOI: 10.1016/j.drugalcdep.2010.08.001
Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere
Abstract
Zeiler et al. (2010) use a simple model to project the potential prevention utility of using pegylated interferon and ribavirin to treat active injecting drug users (IDUs) for HCV infection. Their analysis shows that increasing the level of HCV treatment in Australia could dramatically reduce the prevalence of HCV infection among IDUs. We argue that their projections are under-estimating the possible impact of HCV treatment because their assumed prevalence of active HCV infection in Australia is too high (assumed prevalence of acute plus chronic is 60%) and their model effectively assumes a treatment efficacy of 33%. We replicate their model and show that if these issues are corrected (assuming 45% prevalence of active HCV infection, i.e. ∼60% antibody prevalence and 50% treatment efficacy), then substantially greater impact can be achieved. In addition, we show that the effect of HCV treatment on the primary prevention of HCV increases in populations with lower background HCV prevalence. We also query their finding that HCV treatment should be preferentially targeted to IDUs not on methadone maintenance treatment.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Comment on
-
Impact of a preventive intervention targeting childhood disruptive behavior problems on tobacco and alcohol initiation from age 10 to 13 years.Drug Alcohol Depend. 2009 Mar 1;100(3):228-33. doi: 10.1016/j.drugalcdep.2008.10.004. Epub 2008 Nov 28. Drug Alcohol Depend. 2009. PMID: 19046833 Clinical Trial.
Similar articles
-
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study.PLoS One. 2016 Nov 15;11(11):e0166451. doi: 10.1371/journal.pone.0166451. eCollection 2016. PLoS One. 2016. PMID: 27846264 Free PMC article.
-
Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.Int J Drug Policy. 2007 Oct;18(5):447-51. doi: 10.1016/j.drugpo.2007.01.007. Epub 2007 Feb 21. Int J Drug Policy. 2007. PMID: 17854736 Clinical Trial.
-
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.Drug Alcohol Depend. 2010 Mar 1;107(2-3):244-9. doi: 10.1016/j.drugalcdep.2009.09.015. Drug Alcohol Depend. 2010. PMID: 19926405 Free PMC article. Clinical Trial.
-
Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.Curr Drug Abuse Rev. 2008 Jun;1(2):177-87. doi: 10.2174/1874473710801020177. Curr Drug Abuse Rev. 2008. PMID: 19630716 Review.
-
Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV.Curr HIV/AIDS Rep. 2006 Nov;3(4):176-81. doi: 10.1007/s11904-006-0013-2. Curr HIV/AIDS Rep. 2006. PMID: 17032577 Free PMC article. Review.
Cited by
-
A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region.BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S16. doi: 10.1186/1471-2334-14-S6-S16. Epub 2014 Sep 19. BMC Infect Dis. 2014. PMID: 25252742 Free PMC article. Review.
-
Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.Curr Opin Infect Dis. 2015 Dec;28(6):576-82. doi: 10.1097/QCO.0000000000000216. Curr Opin Infect Dis. 2015. PMID: 26524330 Free PMC article. Review.
-
Hepatitis C virus prevention and care for drug injectors: the French approach.Hepatol Med Policy. 2018 Jun 5;3:7. doi: 10.1186/s41124-018-0033-8. eCollection 2018. Hepatol Med Policy. 2018. PMID: 30288330 Free PMC article.
-
A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.PLoS One. 2014 Feb 27;9(2):e87564. doi: 10.1371/journal.pone.0087564. eCollection 2014. PLoS One. 2014. PMID: 24586281 Free PMC article.
-
Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment.Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1225-32. doi: 10.1007/s10096-011-1433-5. Epub 2011 Oct 6. Eur J Clin Microbiol Infect Dis. 2012. PMID: 21971821
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical